Abstract: A tank body device for measuring slurry density of thermal power generation slurry is provided. Particularly, the tank body includes a clamping assembly, a clinging assembly, and a plurality of push assembly. The clamping assembly, with a base case and closing members, securely holds the tank body. The clinging assembly, featuring telescopic members, articulation pieces, and clamping rings, provides additional support and ensures stability. Each push assembly includes a moving part, push member, and first spring, all integrated into the system. This arrangement enables automatic realignment of the tank body when it tilts, reducing the workload for plant staff and ensuring precise measurement of weight and pressure values.

Abstract: A tank body device for measuring slurry density of thermal power generation slurry is provided. Particularly, the tank body includes a clamping assembly, a clinging assembly, and a plurality of push assembly. The clamping assembly, with a base case and closing members, securely holds the tank body. The clinging assembly, featuring telescopic members, articulation pieces, and clamping rings, provides additional support and ensures stability. Each push assembly includes a moving part, push member, and first spring, all integrated into the system. This arrangement enables automatic realignment of the tank body when it tilts, reducing the workload for plant staff and ensuring precise measurement of weight and pressure values.

Abstract: A sample carrier may include a sample preparation module and an amplification module. A sample mixes with a lysis medium and a nucleic acid amplification medium in the sample preparation module and then flows into a plurality of microfluidic chambers in the amplification module. The microfluidic chambers have disposed therein primers configured to initiate amplification of one or more target nucleic acid sequences corresponding to one or more pathogens. The sample carrier is inserted into an apparatus that includes a plurality of Sight sources and a camera. The light sources illuminate the microfluidic chambers with excitation light, a fluorophore emits fluorescence light indicative of nucleic acid amplification in response to the excitation-light, and the camera captures images of the microfluidic chambers. A target nucleic acid sequence in the sample is indicated by the images showing an increasing fluorescence in a microfluidic chamber that has the primers for that sequence.

Abstract: Techniques for efficient operation of a linear stage in an H-bridge system are provided. In an example, a linear stage can switch between voltage regulation and current regulation over a range of a command signal. The particular regulation mode can depend on the regulation mode of a switched stage of the H-bridge system. Efficiency can be realized by using current regulation of the linear stage when the output voltage of the linear stage moves away from the voltage of a supply rail. Such a control scheme can reduce the voltage across the linear stage for a larger range of the command signal resulting in less heat dissipation of the linear stage compared to conventional control of H-bridge linear stages.

Abstract: Techniques for efficient operation of a linear stage in an H-bridge system are provided. In an example, a linear stage can switch between voltage regulation and current regulation over a range of a command signal. The particular regulation mode can depend on the regulation mode of a switched stage of the H-bridge system. Efficiency can he realized by using current regulation of the linear stage when the output voltage of the linear stage moves away from the voltage of a supply rail. Such a control scheme can reduce the voltage across the linear stage for a larger range of the command signal resulting in less heat dissipation of the linear stage compared to conventional control of H-bridge linear stages.

Abstract: A sample carrier may include a sample preparation module and an amplification module. A sample mixes with a lysis medium and a nucleic acid amplification medium in the sample preparation module and then flows into a plurality of microfluidic chambers in the amplification module. The microfluidic chambers have disposed therein primers configured to initiate amplification of one or more target nucleic acid sequences corresponding to one or more pathogens. The sample carrier is inserted into an apparatus that includes a plurality of Sight sources and a camera. The light sources illuminate the microfluidic chambers with excitation light, a fluorophore emits fluorescence light indicative of nucleic acid amplification in response to the excitation-light, and the camera captures images of the microfluidic chambers. A target nucleic acid sequence in the sample is indicated by the images showing an increasing fluorescence in a microfluidic chamber that has the primers for that sequence.

Abstract: Novel coated substrates comprise a substrate and a coating thereon. The coating comprises a polymeric component and a colorant compound. The colorant compound is produced by reacting an isocyanate compound and an active hydrogen-terminated colorant.